Latest News

 Filter by Provider

Bitwise Asset Management says Bitcoin (CRYPTO: BTC), Ethereum (CRYPTO: ETH), and Solana (CRYPTO: SOL) are expected to reach n

D-Wave Quantum Inc (NYSE:QBTS) shares are trading higher. The company on Tuesday announced the successful completion of its at-the-market offering.

Silver, often overshadowed by its more glamorous counterpart, gold, has recently captured the attention of investors worldwide.

Alnylam Pharma Stock Outlook: For new entrants, chasing the momentum at this point would offer poor risk-reward dynamics.

AMC reached a creditor-backed deal to raise $223 million, convert debt to equity, and settle litigation.

AMD's stock surged 38% in last 3 months due to AI frenzy, outperforming S&P 500 and Nasdaq. Analysts predict 16.78% upside and $6.6B sales upside by 2027.

(BPT) - From prevention to intervention, Our Rescue collaborates with partners and communities around the globe to provide direct services and support to people who are forced into sex trafficking and children who are exploited.

The Elliott Wave analysis for the AUDJPY daily chart shows a counter-trend setup.

Check out the companies making headlines yesterday:

Wedbush analyst Dan Ives predicts a weak performance for Tesla Inc. (NASDAQ: TSLA) amidst a fallout between CEO Elon Musk and President Donald Trump.

BEST BUY CO INC (NYSE:BBY) offers a strong 5.55% dividend yield with consistent growth and solid financial health, making it a candidate for dividend investors.

USD/JPY slumps on USD weakness as trade, fiscal worries mount.

A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who argued it violated program intent.

Mesoblast plans to file a BLA for Revascor by year-end after aligning with FDA on trial design, potency assays, and manufacturing controls.

Tesla stock dropped in early stock market trade Tuesday as Elon Musk and Donald Trump feuded once more.

IBM expands DevOps capabilities with DBmaestro OEM deal to streamline database automation and boost software delivery.

Aurinia Pharmaceuticals (NASDAQ:AUPH) shows strong growth metrics, including surging earnings, revenue, and cash flow, making it a candidate for investors following Louis Navellier’s strategy.

Gold remains steady in a tight range as concerns over US fiscal issues, trade tensions, and potential Fed rate cuts fuel demand.

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

CNBC Host, Jim Cramer is optimistic about Amazon.com Inc. (NASDAQ: AMZN), despite the ongoing tariff pressures. His prediction comes after a conversation with Amazon's CEO, Andy Jassy.

Dan Ives has reiterated his bullish stance on Tesla, positioning it as one of the premier investments in the field of physical AI.

Trump's on-camera f-bomb made headlines—but behind the profanity lies a revealing glimpse into how his impulsive, emotion-driven mind actually works.

UBIQUITI INC (NYSE:UI) meets Louis Navellier’s growth criteria with strong earnings, sales growth, and high ROE. A solid pick for growth investors.

Most Americans are earning less than 1% interest on their savings. Here's how to make your money grow (instead of shrink.)

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

The Centers for Medicare & Medicaid Services (CMS) released a proposed rule on Monday outlining changes to how Medicare pays home health agencies (HHAs) in calendar year (CY) 2026. These updates are required by law and occur annually.

PARKER HANNIFIN CORP (NYSE:PH) meets quality investing criteria with high ROIC, strong EBIT growth, and solid cash flow conversion. A premium valuation may be justified by its profitability and financial health.

The EUR/USD pair continues its bullish climb toward 1.18, supported by dollar weakness and rate cut expectations, though traders eye potential pullbacks near 1.16.

Guggenheim cut McDonald’s price target by $5 to $305 as the burger chain battles tepid demand in the United States, with macro environmental pressure weighing on consumer buying patterns.

Jim Cramer recommends buying Rio Tinto due to its high yield. TG Therapeutics is also a buy, with strong first-quarter sales and potential for market share growth.

IBEX LTD (NASDAQ:IBEX) offers strong growth, profitability, and an attractive valuation, making it a solid pick for GARP investors following Peter Lynch’s strategy.